Literature DB >> 28639151

Central Arterial Function Measured by Non-invasive Pulse Wave Analysis is Abnormal in Patients with Duchenne Muscular Dystrophy.

Thomas D Ryan1, John J Parent2, Zhiqian Gao3, Philip R Khoury3, Elizabeth Dupont3, Jennifer N Smith3, Brenda Wong4, Elaine M Urbina3, John L Jefferies3.   

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by mutation of dystrophin. Cardiovascular involvement includes dilated cardiomyopathy. Non-invasive assessment of vascular function has not been evaluated in DMD. We hypothesize arterial wave reflection is abnormal in patients with DMD. Pulse wave analysis was performed on DMD patients with a SphygmoCor SCOR-PVx System to determine central blood pressure and augmentation index (AIx) as an assessment of arterial wave reflection. Results were compared to a control group. A total of 43 patients with DMD were enrolled, and compared to 43 normal controls. Central systolic blood pressure was lower, while both AIx-75 (7.8 ± 9.6% vs. 2.1 ± 10.4%, p 0.01, DMD vs. normal) and AIx-not corrected (16.8 ± 10.1% vs. -3.6 ± 10.9, p < 0.001, DMD vs. normal) were higher in the DMD compared to control. Using multivariable linear regression model, the variables found to have a significant effect on AIx-not corrected included diagnosis of DMD, height, and heart rate (r 2 = 0.257). The current data suggest that, despite lower central systolic blood pressure, patients with DMD have higher wave reflection when compared to normal controls, which may represent increased arterial stiffness. Overall there appears to be no effect on ventricular systolic function, however the long-term consequence in this group is unknown. Further study is required to determine the mechanism of these differences, which may be related to the effects of systemic steroids or the role of dystrophin in vascular function.

Entities:  

Keywords:  Arterial; Blood pressure; Cardiovascular; Duchenne muscular dystrophy

Mesh:

Year:  2017        PMID: 28639151     DOI: 10.1007/s00246-017-1657-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?

Authors:  Tamara O Thomas; John L Jefferies; Angela Lorts; Jeffrey B Anderson; Zhiqian Gao; D Woodrow Benson; Kan N Hor; Linda H Cripe; Elaine M Urbina
Journal:  Pediatr Cardiol       Date:  2014-11-16       Impact factor: 1.655

2.  Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus.

Authors:  Elaine M Urbina; Thomas R Kimball; Philip R Khoury; Stephen R Daniels; Lawrence M Dolan
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

3.  Insulin resistance and arterial stiffness in healthy adolescents and young adults.

Authors:  E M Urbina; Z Gao; P R Khoury; L J Martin; L M Dolan
Journal:  Diabetologia       Date:  2011-12-23       Impact factor: 10.122

4.  Evidence-based path to newborn screening for Duchenne muscular dystrophy.

Authors:  Jerry R Mendell; Chris Shilling; Nancy D Leslie; Kevin M Flanigan; Roula al-Dahhak; Julie Gastier-Foster; Kelley Kneile; Diane M Dunn; Brett Duval; Alexander Aoyagi; Cindy Hamil; Maha Mahmoud; Kandice Roush; Lauren Bird; Chelsea Rankin; Heather Lilly; Natalie Street; Ram Chandrasekar; Robert B Weiss
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

5.  Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.

Authors:  Subha V Raman; Kan N Hor; Wojciech Mazur; Nancy J Halnon; John T Kissel; Xin He; Tam Tran; Suzanne Smart; Beth McCarthy; Michael D Taylor; John L Jefferies; Jill A Rafael-Fortney; Jeovanna Lowe; Sharon L Roble; Linda H Cripe
Journal:  Lancet Neurol       Date:  2014-12-30       Impact factor: 44.182

Review 6.  Update on the management of Duchenne muscular dystrophy.

Authors:  A Y Manzur; M Kinali; F Muntoni
Journal:  Arch Dis Child       Date:  2008-07-30       Impact factor: 3.791

7.  Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy.

Authors:  W W Dye; R L Gleason; E Wilson; J D Humphrey
Journal:  J Appl Physiol (1985)       Date:  2007-05-24

8.  Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study.

Authors:  Amy S Shah; Sandra Black; R Paul Wadwa; Sarah J Schmiege; Nora F Fino; Jennifer W Talton; Ralph D'Agostino; Richard F Hamman; Elaine M Urbina; Lawrence M Dolan; Stephen R Daniels; Santica M Marcovina; Dana Dabelea
Journal:  J Diabetes Complications       Date:  2015-02-14       Impact factor: 2.852

9.  Increased neointimal thickening in dystrophin-deficient mdx mice.

Authors:  Uwe Rauch; Annelie Shami; Feng Zhang; Virginie Carmignac; Madeleine Durbeej; Anna Hultgårdh-Nilsson
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

10.  Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study.

Authors:  R Paul Wadwa; Elaine M Urbina; Andrea M Anderson; Richard F Hamman; Lawrence M Dolan; Beatriz L Rodriguez; Stephen R Daniels; Dana Dabelea
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 19.112

View more
  5 in total

1.  Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis.

Authors:  Junjie Wang; Qin Fan; Tengbo Yu; Yingze Zhang
Journal:  BMC Genom Data       Date:  2021-12-18

2.  Social stress is lethal in the mdx model of Duchenne muscular dystrophy.

Authors:  Maria Razzoli; Angus Lindsay; Michelle L Law; Christopher M Chamberlain; William M Southern; Madeleine Berg; John Osborn; William C Engeland; Joseph M Metzger; James M Ervasti; Alessandro Bartolomucci
Journal:  EBioMedicine       Date:  2020-03-16       Impact factor: 8.143

3.  Antagonism of the Thromboxane-Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy.

Authors:  James D West; Cristi L Galindo; Kyungsoo Kim; John Jonghyun Shin; James B Atkinson; Ines Macias-Perez; Leo Pavliv; Bjorn C Knollmann; Jonathan H Soslow; Larry W Markham; Erica J Carrier
Journal:  J Am Heart Assoc       Date:  2019-10-30       Impact factor: 5.501

4.  Cardiovascular phenotype of the Dmdmdx rat - a suitable animal model for Duchenne muscular dystrophy.

Authors:  Petra Lujza Szabó; Janine Ebner; Xaver Koenig; Ouafa Hamza; Simon Watzinger; Sandra Trojanek; Dietmar Abraham; Hannes Todt; Helmut Kubista; Klaus Schicker; Séverine Remy; Ignacio Anegon; Attila Kiss; Bruno K Podesser; Karlheinz Hilber
Journal:  Dis Model Mech       Date:  2021-02-22       Impact factor: 5.732

5.  The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy.

Authors:  Sarah E Henson; Sean M Lang; Philip R Khoury; Cuixia Tian; Meilan M Rutter; Elaine M Urbina; Thomas D Ryan; Michael D Taylor; Tarek Alsaied
Journal:  J Am Heart Assoc       Date:  2021-09-25       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.